Drug
tildrakizumab-asmn
Marketed as ILUMYA.
Generic name
tildrakizumab-asmn
Brand names
ILUMYA
First FDA approval
2018-03-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761067 | ILUMYA | 2018-03-20 | SUN PHARMA GLOBAL |
Manufacturers
SUN PHARMA GLOBAL
Frequently asked questions
When was tildrakizumab-asmn FDA approved?
Earliest FDA approval on record: 2018-03-20.
What brand names are sold as tildrakizumab-asmn?
ILUMYA.
Sources
Appeal a tildrakizumab-asmn denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com